17-6080827-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015253.2(WSCD1):c.169G>A(p.Val57Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000126 in 1,607,988 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015253.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
WSCD1 | NM_015253.2 | c.169G>A | p.Val57Met | missense_variant | 2/9 | ENST00000317744.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
WSCD1 | ENST00000317744.10 | c.169G>A | p.Val57Met | missense_variant | 2/9 | 1 | NM_015253.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000677 AC: 103AN: 152184Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000138 AC: 32AN: 231720Hom.: 0 AF XY: 0.000110 AC XY: 14AN XY: 127460
GnomAD4 exome AF: 0.0000680 AC: 99AN: 1455686Hom.: 0 Cov.: 31 AF XY: 0.0000525 AC XY: 38AN XY: 723984
GnomAD4 genome AF: 0.000676 AC: 103AN: 152302Hom.: 0 Cov.: 33 AF XY: 0.000671 AC XY: 50AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 16, 2023 | The c.169G>A (p.V57M) alteration is located in exon 2 (coding exon 1) of the WSCD1 gene. This alteration results from a G to A substitution at nucleotide position 169, causing the valine (V) at amino acid position 57 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at